| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | DHA | 81.13842744 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 101.5614678 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 102.2104451 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 102.6999219 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 108.5646662 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 113.0513161 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 148.7383667 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 153.3246273 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 2182.793165 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 2966.894089 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3049.609512 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3104.665507 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3421.538462 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3457.230381 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3676.333957 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3708.413897 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3893.647719 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 3957.600118 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 4163.142074 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 4209.243425 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 4272.987933 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 4403.083284 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 4462.009831 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 4602.083707 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 5823.323659 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 5933.265794 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 6608.663511 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 6661.228239 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 6854.935403 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 7220.5 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | DHA | 9147.729915 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | 11904.39492 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | DHA | intensity | Wild-type | LPS | |
| Reversed phase UNSPECIFIED ION MODE | DHA | intensity | Wild-type | LPS+antiPla2g5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|